[Application of NF-kappaB Reporter and Dual-Luciferase Assays in the Measure of Bioactivity of Interleukin-1Beta and Interleukin-1 Receptor Antagonist].

Ying-mei Zhang,Ying Wang,Qian-mei Xu,Bing-feng Lv,Da-long Ma
DOI: https://doi.org/10.3321/j.issn:1671-167x.2006.06.019
2006-01-01
Abstract:OBJECTIVE:To develop a reporter gene system based on transient transfections with a NF-kappaB responsive reporter gene to detect the bioactivity of IL-1beta and IL-1 receptor antagonist.METHODS:NF-kappaB reporter and Dual-Luciferase assays were applied to measure the bioactivity of IL-1beta and IL-1 receptor antagonist in mouse EL4 cells (some subclones of EL4 cells expressed high level of IL-1 receptor on cell surface). pNF-kappaB-luc and pRL-TK, used as an internal control, were co-transfected into EL4 cells and then the IL-1beta was added.RESULTS:The results indicated that IL-1beta was able to induce the expression of this luciferase, which could be blocked by IL-1 receptor antagonist. The optimal dose of IL-1beta was 5 microg/L in Dual-Luciferase assay, whose bioactivity can be effectively inhibited by IL-1ra at 50 microg/L.CONCLUSION:We have established a new method to detect the bioactivity of IL-1beta and IL-1 receptor antagonist, which can give repeatable results.
What problem does this paper attempt to address?